Thank you for your interest in our webinar hosted on March 11, 2020. Though you missed our live presentation, we are delighted to provide you with the recording of this informative session you can view on demand at your leisure.
Access the recording: DTx pricing & reimbursement: A journey into the manufacturer mindset
Digital solutions are increasingly pushing to the forefront of the healthcare discussion. Driven by patients’ interest for improved access to healthcare, several innovative players in the space have generated appealing clinical data on the benefits of digital. Healthcare systems have seen the potential digital has to improve the status quo for all stakeholders involved and have adapted accordingly, with new policies to improve their use of digital solutions.
Having explored this topic with companies at the forefront of digital therapeutics (DTx) development – in a recent study conducted with the Digital Therapeutics Alliance (DTA) – Ipsos has gathered and digested the manufacturer’s perspective on payer discussions and negotiations.
View the webinar and listen as Ipsos and DTA experts share a review of manufacturer experiences with payer assessments of DTx for pricing and reimbursement purposes, in both the US and EU3 (France, Germany & UK).
Attend our session and take a journey into the manufacturer mindset on the requirements, opportunities and challenges for DTx.
Key takeaways from the presentation include:
- A summary of DTx payer drivers
- Key learnings on DTx pricing & reimbursement pathways
- An understanding the challenges and opportunities of DTx pricing & reimbursement
Davide Panciera, Senior Consultant, Market Access, Ipsos
Megan Coder, Executive Director, Digital Therapeutics Alliance